Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. The investigation follows a July 8, 2026 whistleblower complaint by a former executive alleging accounting irregularities that artificially inflated previously reported and projected financial results, including Adjusted EBITDA, and that millions of dollars in operating expenses were systematically misclassified as capital expenditures. On that day, Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share. Kaplan Fox is a nationally recognized plaintiffs' securities litigation firm that has recovered more than $10 billion for clients and classes.
Alignment Healthcare LLCWhistleblower complaint alleges accounting irregularities and securities law violations, causing stock to drop 16.7%.
